Peroxisome Proliferator-Activated Receptor Agonists as Potential Therapeutic Agents in Multiple Sclerosis

Author(s): Masaaki Niino

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 7 , Issue 11 , 2007

Become EABM
Become Reviewer
Call for Editor


Peroxisome proliferator-activated receptors (PPARs) have been extensively studied for gene regulation in glucose and lipid metabolism. It has been recently implicated that PPARs regulate cellular proliferation and inflammatory responses; some agonists for PPARs ameliorate experimental autoimmune encephalomyelitis, a model of multiple sclerosis (MS) in humans. This article will outline current experimental evidence suggesting potential clinical benefits for patients with MS.

Keywords: PPAR, multiple sclerosis, experimental autoimmune encephalomyelitis, cytokine, inflammation

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [1129 - 1135]
Pages: 7
DOI: 10.2174/138955707782331687
Price: $65

Article Metrics

PDF: 3